Skip to content
![Reconstructing tumor microenvironment with patient-derived organoids for derisking Immuno-Oncology therapies]()
October 24, 2024
Reconstructing tumor microenvironment with patient-derived organoids for derisking Immuno-Oncology therapies
read more
![Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy]()
April 29, 2024
Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy
read more
![Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model]()
April 29, 2024
Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model
read more
![A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors]()
April 29, 2024
A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors
read more
![Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy]()
May 15, 2023
Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy
read more
![Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies]()
May 15, 2023
Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies
read more
![Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies]()
January 16, 2023
Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies
read more
